LabCorp
LH
$201.48
Share price
1.02%
Change (1 day)
-12.52%
Change (1 year)
Categories
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.
Revenue for LabCorp (LH)
Revenue in 2023 (TTM): $12.90 B
According to LabCorp's latest financial reports the company's current revenue (TTM) is $12.90 B. In 2022 the company made a revenue of $13.36 B a decrease over the years 2021 revenue that were of $16.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for LabCorp from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $12.90 B | -3.46% |
| 2022 | $13.36 B | -17.1% |
| 2021 | $16.12 B | 15.33% |
| 2020 | $13.97 B | 20.98% |
| 2019 | $11.55 B | 1.95% |
| 2018 | $11.33 B | 9.4% |
| 2017 | $10.35 B | 7.44% |
| 2016 | $9.64 B | 11.08% |
| 2015 | $8.68 B | 44.39% |
| 2014 | $6.01 B | 3.5% |
| 2013 | $5.80 B | 2.41% |
| 2012 | $5.67 B | 2.33% |
| 2011 | $5.54 B | 10.76% |
| 2010 | $5.00 B | 6.59% |
| 2009 | $4.69 B | 4.21% |
| 2008 | $4.50 B | 10.74% |
| 2007 | $4.06 B | 13.3% |
| 2006 | $3.59 B | 7.91% |
| 2005 | $3.32 B | 7.87% |
| 2004 | $3.08 B | 4.95% |
| 2003 | $2.93 B | 17.21% |
| 2002 | $2.50 B | 14% |
| 2001 | $2.19 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | $3.66 B | -71.62% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $9.25 B | -28.29% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $0.22 B | -98.26% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.59 B | -95.41% | 🇺🇸 USA |
 Qiagen QGEN | $1.96 B | -84.77% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $12.8 M | -99.90% | 🇺🇸 USA |